Angelique N. Voorberg
Groningen, GR 9713GZ, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Transcriptomics- and Genomics-Guided Drug Repurposing for the Treatment of Vesicular Hand Eczema.
Journal: Pharmaceutics
Published: February 19, 2024
Transcriptional differences between vesicular hand eczema and atopic dermatitis.
Journal: Contact dermatitis
Published: July 04, 2023
Efficacy and safety of dupilumab in patients with severe chronic hand eczema with inadequate response or intolerance to alitretinoin: a randomized, double-blind, placebo-controlled phase IIb proof-of-concept study.
Journal: The British journal of dermatology
Published: February 24, 2023
Efficacy and safety of oral alitretinoin versus oral azathioprine in patients with severe chronic hand eczema: Results from a prematurely discontinued randomized controlled trial.
Journal: Contact dermatitis
Published: April 26, 2022
Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis.
Journal: Acta dermato-venereologica
Published: January 31, 2022
The long-term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis-52 week results from the Dutch BioDay Registry.
Journal: Contact dermatitis
Published: November 22, 2021
Prevalence and Severity of Hand Eczema in the Dutch General Population: A Cross-sectional, Questionnaire Study within the Lifelines Cohort Study.
Journal: Acta dermato-venereologica
Published: October 19, 2021
Guidelines for diagnosis, prevention, and treatment of hand eczema.
Journal: Contact dermatitis
Published: October 17, 2021
Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab - a cross-sectional study from the BioDay registry.
Journal: The Journal of dermatological treatment
Published: June 21, 2021
Vesicular hand eczema transcriptome analysis provides insights into its pathophysiology.
Journal: Experimental dermatology
Published: April 22, 2021
Prevalence of adult atopic dermatitis in the general population, with a focus on moderate-to-severe disease: results from the Lifelines Cohort Study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 14, 2021
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry.
Journal: Journal of the American Academy of Dermatology
Published: April 04, 2020
Last Updated: 09/26/2026